NUVL
Nuvalent Inc
NASDAQ: NUVL · HEALTHCARE · BIOTECHNOLOGY
$99.10
-2.79% today
Updated 2026-04-29
Market cap
$8.01B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-5.85
Dividend yield
—
52W range
$64 – $113
Volume
0.6M
Nuvalent Inc (NUVL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-36.70%
ROA
-20.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-11.81M | — | — | — |
| 2020 | $0.00 | $-14.56M | — | — | — |
| 2021 | $0.00 | $-46.34M | — | — | — |
| 2022 | $0.00 | $-73.35M | — | — | — |
| 2023 | $0.00 | $-126.22M | — | — | — |
| 2024 | $0.00 | $-260.76M | — | — | — |
| 2025 | $0.00 | $-425.38M | — | — | — |